427 related articles for article (PubMed ID: 29307231)
1. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities.
Zaporozhchenko IA; Ponomaryova AA; Rykova EY; Laktionov PP
Expert Rev Mol Diagn; 2018 Feb; 18(2):133-145. PubMed ID: 29307231
[TBL] [Abstract][Full Text] [Related]
2. The potential of circulating cell free RNA as a biomarker in cancer.
Cheung KWE; Choi SR; Lee LTC; Lee NLE; Tsang HF; Cheng YT; Cho WCS; Wong EYL; Wong SCC
Expert Rev Mol Diagn; 2019 Jul; 19(7):579-590. PubMed ID: 31215265
[No Abstract] [Full Text] [Related]
3. Current and emerging bladder cancer biomarkers with an emphasis on urine biomarkers.
Lopez-Beltran A; Cheng L; Gevaert T; Blanca A; Cimadamore A; Santoni M; Massari F; Scarpelli M; Raspollini MR; Montironi R
Expert Rev Mol Diagn; 2020 Feb; 20(2):231-243. PubMed ID: 31795775
[No Abstract] [Full Text] [Related]
4. Liquid Biopsy: General Concepts.
Poulet G; Massias J; Taly V
Acta Cytol; 2019; 63(6):449-455. PubMed ID: 31091522
[TBL] [Abstract][Full Text] [Related]
5. Biosensors for liquid biopsy: circulating nucleic acids to diagnose and treat cancer.
Bellassai N; Spoto G
Anal Bioanal Chem; 2016 Oct; 408(26):7255-64. PubMed ID: 27497966
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of emerging biomarkers in prostate cancer liquid biopsies.
Boerrigter E; Groen LN; Van Erp NP; Verhaegh GW; Schalken JA
Expert Rev Mol Diagn; 2020 Feb; 20(2):219-230. PubMed ID: 31577907
[No Abstract] [Full Text] [Related]
7. Liquid biopsy for liver diseases.
Mann J; Reeves HL; Feldstein AE
Gut; 2018 Dec; 67(12):2204-2212. PubMed ID: 30177542
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in circulating nucleic acids in oncology.
Otandault A; Anker P; Al Amir Dache Z; Guillaumon V; Meddeb R; Pastor B; Pisareva E; Sanchez C; Tanos R; Tousch G; Schwarzenbach H; Thierry AR
Ann Oncol; 2019 Mar; 30(3):374-384. PubMed ID: 30753271
[TBL] [Abstract][Full Text] [Related]
9. Potential of circulating biomarkers in liquid biopsy diagnostics.
Yeo JC; Lim CT
Biotechniques; 2018 Oct; 65(4):187-189. PubMed ID: 30284936
[No Abstract] [Full Text] [Related]
10. Liquid biopsy in the clinical management of bladder cancer: current status and future developments.
Kouba E; Lopez-Beltran A; Montironi R; Massari F; Huang K; Santoni M; Chovanec M; Cheng M; Scarpelli M; Zhang J; Cimadamore A; Cheng L
Expert Rev Mol Diagn; 2020 Feb; 20(2):255-264. PubMed ID: 31608720
[No Abstract] [Full Text] [Related]
11. Liquid Biopsy: From Basic Research to Clinical Practice.
Macías M; Alegre E; Díaz-Lagares A; Patiño A; Pérez-Gracia JL; Sanmamed M; López-López R; Varo N; González A
Adv Clin Chem; 2018; 83():73-119. PubMed ID: 29304904
[TBL] [Abstract][Full Text] [Related]
12. Targets, pitfalls and reference materials for liquid biopsy tests in cancer diagnostics.
Geeurickx E; Hendrix A
Mol Aspects Med; 2020 Apr; 72():100828. PubMed ID: 31711714
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Educated Platelet RNA and Circulating Free RNA: Emerging Liquid Biopsy Markers for Different Tumor Types.
Hu H; Song H; Han B; Zhao H; He J
Front Biosci (Landmark Ed); 2024 Feb; 29(2):80. PubMed ID: 38420812
[TBL] [Abstract][Full Text] [Related]
14. Liquid Biopsy: A New Tool in Oncology.
Costa JL; Schmitt FC
Acta Cytol; 2019; 63(6):448. PubMed ID: 31266005
[No Abstract] [Full Text] [Related]
15. Circulating Tumor Cells and Circulating Tumor DNA: Challenges and Opportunities on the Path to Clinical Utility.
Ignatiadis M; Lee M; Jeffrey SS
Clin Cancer Res; 2015 Nov; 21(21):4786-800. PubMed ID: 26527805
[TBL] [Abstract][Full Text] [Related]
16. Utilising extracellular vesicles for early cancer diagnostics: benefits, challenges and recommendations for the future.
Pink RC; Beaman EM; Samuel P; Brooks SA; Carter DRF
Br J Cancer; 2022 Feb; 126(3):323-330. PubMed ID: 35013578
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy approach in the management of prostate cancer.
Riaz IB; Wang L; Kohli M
Transl Res; 2018 Nov; 201():60-70. PubMed ID: 29936077
[TBL] [Abstract][Full Text] [Related]
18. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
19. New perspectives in liquid biopsy for glioma patients.
Pasqualetti F; Rizzo M; Franceschi S; Lessi F; Paiar F; Buffa FM
Curr Opin Oncol; 2022 Nov; 34(6):705-712. PubMed ID: 36093876
[TBL] [Abstract][Full Text] [Related]
20. Life and death of circulating cell-free DNA.
Kustanovich A; Schwartz R; Peretz T; Grinshpun A
Cancer Biol Ther; 2019; 20(8):1057-1067. PubMed ID: 30990132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
